Immutep Limited
PRRUF
$0.04
-$0.01-21.11%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 92.84% | 86.96% | 5.96% | 3.97% | 49.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.84% | 86.96% | 6.47% | 4.48% | 49.11% |
| Cost of Revenue | 85.39% | 79.72% | 66.14% | 63.03% | 23.93% |
| Gross Profit | -84.33% | -78.69% | -71.47% | -68.26% | -21.03% |
| SG&A Expenses | 29.17% | 25.23% | 5.86% | 3.88% | -11.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.34% | 71.92% | 56.44% | 53.51% | 17.13% |
| Operating Income | -75.49% | -70.13% | -60.13% | -57.13% | -14.21% |
| Income Before Tax | -101.92% | -95.75% | -76.69% | -73.38% | -5.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.92% | -95.75% | -76.69% | -73.38% | -5.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.92% | -95.75% | -76.69% | -73.38% | -5.40% |
| EBIT | -75.49% | -70.13% | -60.13% | -57.13% | -14.21% |
| EBITDA | -71.34% | -66.10% | -58.17% | -54.67% | -18.88% |
| EPS Basic | -100.00% | -92.31% | -48.28% | -44.83% | 13.79% |
| Normalized Basic EPS | -103.23% | -93.75% | -50.00% | -44.44% | 13.89% |
| EPS Diluted | -100.00% | -92.31% | -48.28% | -44.83% | 13.79% |
| Normalized Diluted EPS | -103.23% | -93.75% | -50.00% | -44.44% | 13.89% |
| Average Basic Shares Outstanding | 1.22% | 1.22% | 19.93% | 19.93% | 22.53% |
| Average Diluted Shares Outstanding | 1.22% | 1.22% | 19.93% | 19.93% | 22.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |